UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
If you're over 50 and haven't saved for retirement, it's not too late. Learn essential steps to secure your financial future.
28,655 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Meta's exploration of renting idle GPU capacity as a cloud resource has sparked a heated, split view on Wall Street. ...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
As talks on reform gain momentum, the social security cuts edge could reshape lifetime retirement income for millions...
Netflix faces a pivotal earnings week as the stock hovers around $78. This story examines the netflix price predictio...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
Rising gray divorces are pushing older homeowners to consider reverse mortgages as a financial lever. A new wave of s...
Massachusetts’ Vineyard Wind project has completed construction, delivering 800 MW to the region and signaling a majo...
A fresh passively managed strategy centers on established dividend payers to deliver roughly $6,500 a year from a $10...
A sharp spike in local impact fees in Manatee County jeopardizes Live Local housing projects as developers and lawmak...
A leading fiscal watchdog warns that the trump administration’s proposed capital gains policy could lift the national...